Access cutting-edge epidermolysis bullosa, dystrophic treatment through this clinical trial at a research site in Cincinnati. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Cincinnati location
Preparing your pre-screening questions…
Access epidermolysis bullosa, dystrophic specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related epidermolysis bullosa, dystrophic treatment provided free
Check if you qualify for this epidermolysis bullosa, dystrophic clinical trial in Cincinnati, OH
No-Cost Study Care
Local to Cincinnati
Convenient for OH residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
In patients with epidermolysis bullosa (EB), collagen does not form properly, so their skin is very fragile and blisters easily. Such patients are also at greatly increased risk of developing skin cancers. Filsuvez is a topical gel used to promote healing of skin lesions in patients with certain types of EB. In this observational study, patients with either dystrophic EB (DEB) or junctional EB (JEB) will receive standard of care treatment, whether Filsuvez or something else, and will be followed for a minimum of 3 years. The main purpose is to see if the use of Filsuvez affects the likelihood of developing skin malignancies in these patient populations.
Sponsor: Chiesi Farmaceutici S.p.A.
Yes, this clinical trial (NCT06423573) has an active research site in Cincinnati, OH that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for epidermolysis bullosa, dystrophic treatment options in Cincinnati, OH, this clinical trial (NCT06423573) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Cincinnati research site is actively enrolling participants for this clinical trial. You'll receive care from experienced epidermolysis bullosa, dystrophic specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all epidermolysis bullosa, dystrophic clinical trials near you to find additional studies recruiting in your area.
See all sleep apnea clinical trials recruiting in Cincinnati — not just this study.
Browse Sleep Apnea Trials in Cincinnati →